2 Asthma, COPD, and Hiccups Flashcards
Mild asthma
s/s: dyspnea only with activity
initial PEF β₯70% predicted or personal best
cc: prompt relief with inhaled SABA
Moderate asthma
s/s: dyspnea interferes with or limits usual activity
initial PEF 40-69 predicted or personal best
cc: relief from frequent inhaled SABA. Symptoms for 1-2 days after oral corticosteroids begun
Severe asthma
s/s: dyspnea at rest; interferes with conversation
initial PEF **<40% predicted or personal best
cc: partial relief from frequent inhaled SABA. Symptoms for β₯3 days after oral corticosteroids begun
Life-threatening asthma
ss: too dyspneic to speak; perspiring π°
initial PEF β€25% predicted or personal best
cc: minimal or no relief from frequent inhaled SABA;
IV steroids; adjunctive therapy; needs ED or ICU
Rirsk factors for death from asthma
past history of severe exacerbation
β₯2 hospitalizations for asthma in the past year
β₯3 canisters per month of inhaled SABA
β₯4 ED visits for asthma in the past year
difficulty perceiving airflow obstrution or its severity
low SE status or inner-city resident
illicit drug use
psychiatric disease or medical comorbidities
Heart failure can largely be excluded in patients with acute dyspnea and NTproBNP of
NT-pro-BNP β€300 pg/mL
| BNP <100 pg/mL
only drug thatβs US FDA approved for intractable hiccups
Chlorpromazine
initial dose in ED:
25-50 mg IV, repeat in 2-4 h if needed
maintenance dose on discharge
25-50 mg PO 3-4x/day
- benign and self-limited hiccups: <48 hours
- persistent: >48 hours
- intractable - last longer than a month
Other drugs for hiccups
Metoclopramide 10 mg IV or IM
MD: 10-20 mg PO 3x/day for 10 days
Haloperidol 2-5 mg IM
MD: 2-4 mg PO 3x/day
Nifedipine 10-20 mg PO
MD: 10-20 mg PO 3-4x/day
Gabapentin 100 mg
MD: 100 mg PO 3x/day, titrated up to 120 mg/day (?)
Physical maneuvers as management for hiccups
FIQS
Foreign body removal
Ice water, sip
Quickly drink water
Sugar, swallow a teaspoon
Classification of COPD severity
mild: FEV1 β₯80% pred
mod: FEV1 50-79%
SEV: FEV1 30-49%
very sev: FEV1 <30%
Target SpO2 for COPD patients
88-92%
Doses of magnesium sulfate for status asthmaticus
1-2g IV over 30 minutes
Nebulization:
95 mg of nebulized MgSO4 in 4 divided doses 20mins apart
384 mg of nebulized MgSO4 in sterile water (?)
Other drugs for status asthmaticus
KETAMINE
IV bolus dose of 0.15 mg/kg
then infusion of 0.25 mg/kg/hour
EPINEPHRINE
SC or IM, 0.5 mg (standard adult EpiPen dose) π
HeliOx
80% helium, 20% oxygen
Inclusions for NIV
Acidosis <7.36
Hypercapnea, PaCO2 >50 mmHg
Oxygen deficit, PaO2 <60 mmHg or SaO2 <90%
Severe dyspnea with clinical signs such as respiratory muscle fatigue or increased work of breathing
Exclusions for NIV
Respiratory arrest
High aspiration risk
Viscous or copious secretions
CV instability
Burns
Change in mental status; uncooperative patient
Recent facial or gastroesophageal surgery
Craniofacial trauma
Fixed nasopharyngeal abnoramalities
Extreme obesity